Stop guessing which AI tool to use. Join AI Africa to discover tested AI tools, save your favourites, and use AI with a smile!
Free Account Ends Soon!
Access verified and curated tools
Bookmark tools for quick access
Get notified about new tools
The United States and China are fierce competitors in artificial intelligence. Now, they are also preparing a direct way to communicate when advanced AI goes seriously wrong. Following a three-day summit in Washington, U.S. President Donald Trump and Chinese President Xi Jinping agreed to establish a bilateral communication channel for serious AI-related incidents. The agreement is being described as an “AI hotline.”
Imagine receiving an intelligence report saying a Chinese ship is carrying materials linked to a nuclear weapons programme. You do not have hours to debate it. You act. That is reportedly what nearly happened earlier this year. U.S. military aircraft were already in the air, and armed personnel were preparing to board a Chinese vessel in the Middle East when officials discovered something deeply concerning: The intelligence was wrong. And an AI chatbot had helped produce it.
What if Artificial Intelligence got a new name? President Donald Trump has an idea. Actually, he has three. On Saturday, September 19, Trump asked his followers on Truth Social to vote on whether “Artificial Intelligence” should be renamed Superior Intelligence, Extreme Intelligence, or Supreme Intelligence. But that was only the beginning. A few hours later, Trump announced something much bigger:
Imagine two countries racing to build the world’s most powerful AI systems. Now imagine those same countries agreeing that if something goes seriously wrong, they should at least tell each other. That is the conversation happening between the United States and China. Ahead of a planned meeting between U.S. President Donald Trump and Chinese President Xi Jinping in Washington on September 24
What happens when one of the world's most powerful AI executives is discussing whether artificial intelligence should slow down and the US president suddenly calls him? You put him on speaker. That is exactly what happened on Monday at the All-In Summit in Los Angeles, where Nvidia CEO Jensen Huang was discussing the growing debate over AI safety when his phone started ringing. The caller? Donald Trump. Huang answered.
The AI world is asking one big question right now: Are we moving too fast? But US President Donald Trump appears to have a different priority: making sure China does not win the AI race. Speaking during a visit to Ireland on Sunday, Trump dismissed growing warnings about the dangers of rapidly developing artificial intelligence, arguing that some of the predictions are exaggerated.
The debate over how fast AI should develop has just become a lot more complicated. Anthropic CEO Dario Amodei recently called on the AI industry to slow the development of increasingly powerful AI systems, arguing that the technology is advancing faster than society’s ability to manage its risks. But China is not buying it. China’s state-backed Global Times has described Amodei’s proposal as a “Cold War playbook”
AI companies have spent years racing to build smarter and more powerful models. Now, one of the biggest names in the industry is saying something unexpected: Maybe they need to slow down. Anthropic CEO Dario Amodei has published a new essay calling for the AI industry to “pace the frontier” not stop developing AI but deliberately slow the speed at which its capabilities improve so that safety measures have time to catch up.
Imagine spending billions of dollars building some of the world's most powerful AI models only to discover that someone else may be repeatedly questioning your AI, collecting its answers, and using them to build a competing system. That is essentially the accusation now coming from the United States.
What if a drug designed to help damaged lungs could also make some of the body's biological signals look younger? That sounds like science fiction. But a new study published in Nature Biotechnology has given scientists a reason to take the idea seriously, although there is a very important catch. Researchers studying rentosertib, an experimental drug from AI-focused biotech company Insilico Medicine, found that patients who received the drug showed lower predicted biological ages
Explore